Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Roll-over study to assess long term safety in patients who are ongoing prior global study.

Protocol: OSU-17288

Full Title

An open label, multi-center roll-over study to assess long term safety in patients who are ongoing or have completed a prior global Novartis or GSK sponsored Tafinlar (dabrafenib) and/or Mekinist (trametinib) study and are judged by the investigator to benefit from continued treatment.